Clinical Trial Update: Comparative Efficacy Evaluation of Lipids When Treated With Niaspan & Statin or Other Lipid-Modifying Therapies-COMPELL [Phase 4]

View source ↗

Summary

A Phase 4 trial (COMPELL) sponsored by Kos Pharmaceuticals evaluated the comparative efficacy of Niaspan (niacin extended-release) plus statin or other lipid-mo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atherosclerosis
• Coronary Artery Disease
• Diabetes Mellitus
• Dyslipidemia
• Stroke

Drugs mentioned

• Niaspan (niacin (nicotinic acid))
• Statin therapy (statin)

Snippet

Sponsor: Kos Pharmaceuticals | Conditions: Dyslipidemia, Coronary Heart Disease | Phase 4 | Status: COMPLETED